246 related articles for article (PubMed ID: 23314836)
21. An imaging study of parkinsonism among African-Caribbean and Indian London communities.
Hu MT; Chaudhuri KR; Jarosz J; Yaguez L; Brooks DJ
Mov Disord; 2002 Nov; 17(6):1321-8. PubMed ID: 12465076
[TBL] [Abstract][Full Text] [Related]
22. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
Raffel DM; Koeppe RA; Little R; Wang CN; Liu S; Junck L; Heumann M; Gilman S
J Nucl Med; 2006 Nov; 47(11):1769-77. PubMed ID: 17079809
[TBL] [Abstract][Full Text] [Related]
23. Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism.
Akdemir ÜÖ; Tokçaer AB; Karakuş A; Kapucu LÖ
Clin Nucl Med; 2014 Mar; 39(3):e220-6. PubMed ID: 24321825
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
[TBL] [Abstract][Full Text] [Related]
25.
Meyer PT; Frings L; Rücker G; Hellwig S
J Nucl Med; 2017 Dec; 58(12):1888-1898. PubMed ID: 28912150
[TBL] [Abstract][Full Text] [Related]
26. Automatic covariance pattern analysis outperforms visual reading of
Buchert R; Wegner F; Huppertz HJ; Berding G; Brendel M; Apostolova I; Buhmann C; Dierks A; Katzdobler S; Klietz M; Levin J; Mahmoudi N; Rinscheid A; Rogozinski S; Rumpf JJ; Schneider C; Stöcklein S; Spetsieris PG; Eidelberg D; Wattjes MP; Sabri O; Barthel H; Höglinger G;
Mov Disord; 2023 Oct; 38(10):1901-1913. PubMed ID: 37655363
[TBL] [Abstract][Full Text] [Related]
27. Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning.
Zhao Y; Wu P; Wu J; Brendel M; Lu J; Ge J; Tang C; Hong J; Xu Q; Liu F; Sun Y; Ju Z; Lin H; Guan Y; Bassetti C; Schwaiger M; Huang SC; Rominger A; Wang J; Zuo C; Shi K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2798-2811. PubMed ID: 35588012
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.
Niccolini F; Politis M
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2244-2254. PubMed ID: 27470326
[TBL] [Abstract][Full Text] [Related]
29. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
[TBL] [Abstract][Full Text] [Related]
31. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
[TBL] [Abstract][Full Text] [Related]
32. Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Ko JH; Lee CS; Eidelberg D
J Cereb Blood Flow Metab; 2017 Feb; 37(2):683-693. PubMed ID: 26980757
[TBL] [Abstract][Full Text] [Related]
33. IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement.
Derlin T; Afzal W; Wilke F; Apostolova I; Klutmann S; Meyer PT; Buhmann C; Hesse S; Buchert R
Nuklearmedizin; 2010; 49(4):139-47. PubMed ID: 20502846
[TBL] [Abstract][Full Text] [Related]
34. FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome.
Parmera JB; Coutinho AM; Aranha MR; Studart-Neto A; de Godoi Carneiro C; de Almeida IJ; Fontoura Solla DJ; Ono CR; Barbosa ER; Nitrini R; Buchpiguel CA; Brucki SMD
Mov Disord; 2021 Mar; 36(3):651-661. PubMed ID: 33206389
[TBL] [Abstract][Full Text] [Related]
35. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
36. Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.
Garraux G; Phillips C; Schrouff J; Kreisler A; Lemaire C; Degueldre C; Delcour C; Hustinx R; Luxen A; Destée A; Salmon E
Neuroimage Clin; 2013; 2():883-93. PubMed ID: 24179839
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
Walker Z; Gandolfo F; Orini S; Garibotto V; Agosta F; Arbizu J; Bouwman F; Drzezga A; Nestor P; Boccardi M; Altomare D; Festari C; Nobili F;
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1534-1545. PubMed ID: 29779045
[TBL] [Abstract][Full Text] [Related]
38. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
[TBL] [Abstract][Full Text] [Related]
40. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.
Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Kim JS
Clin Nucl Med; 2017 Feb; 42(2):e80-e87. PubMed ID: 27922865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
